S.2862: Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014

About This Bill

  • Introduced Sept. 18, 2014
  • Latest Major Action Sept. 18, 2014

Bill Cosponsors

2 (1 Democrat, 1 Republican)

Bill Summary

Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 - Amends the Controlled Substances Act to direct the Attorney General, within 45 days of receiving a recommendation from the Secretary of Health and Human Services (HHS) to add a drug or substance that has never been marketed in the United States to a schedule of controlled substances, to issue an interim final rule under the exception for good cause, placing...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with S.2862.

Bill Actions

Date Description
Sept. 18, 2014
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sept. 18, 2014

Introduced in the Senate by Orrin G. Hatch (R-Utah)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page